Graduated in physics and Nano Science from Aarhus University and received his PhD in medical research from the same university. Professor and head of MR Research at the MR-Research Center, Department of Clinical Medicine, Aarhus University, Denmark.
His main research focus has been on introducing the novel imaging methodology Dynamic Nuclear Polarization for early identification and monitoring of the disease diabetic nephropathy.
Professor Ferdia Gallagher is a Cancer Research UK Senior Research Fellow, Head of the Department of Radiology at the University of Cambridge, and an honorary Consultant Radiologist at Addenbrooke’s Hospital in Cambridge.
He leads the Clinical Molecular Imaging Group in the Department of Radiology and the preclinical imaging group in the Anne McLaren Building on the Cambridge Biomedical Campus. He has expertise in metabolic imaging using MRI and PET for stratification of tumours and response to therapy.
The group has a particular interest in understanding the molecular basis of metabolism in a range of cancers, and how novel non-invasive imaging methods to probe this metabolism can be translated into patient studies. The ultimate goal of his work is to develop new imaging biomarkers of early detection and treatment response for patient benefit.
Received his PhD from the University of Wisconsin-Madison in Medical Physics. Currently employed as Assistant Professor at UCSF, USA.
He uses advanced imaging techniques to provide physiologic and metabolic information with MRI, with a focus on the development of novel and rapid acquisition strategies and reconstruction methods for spectroscopic imaging on preclinical and clinical systems.
He leads the technical aspects of the DNP polarization and EPI sequence developments for HP C-13 MR human studies.
Received his PhD in MR spectroscopy from the University of Edinburgh. Professor at the University of Sheffield and head of POLARIS (Pulmonary, Lung and Respiratory Imaging Sheffield).
His research focuses on the physics and engineering and clinical applications of hyperpolarized gas (3He and 129Xe) and proton MRI in the lungs and pulmonary vasculature.
Graduated in Physics from the University of Pavia and received his PhD in Physics from EPFL, Lausanne. He has a shared academic position between EPFL (junior group leader) and the Technical University of Denmark (Assistant Professor). He recently joined the company Polarize as application manager.
His research focuses on the physical understanding and technological developments of dDNP.
PhD in Physics at University of Illinois, Champaign-Urbana, and EPFL. Currently manager of the Hyperpolarized 13C Imaging program at GE HealthCare.
His expertise is in instrumentation and methods for preclinical and clinical hyperpolarized 13C MR.
Myriam Chaumeil is the Head of Research, HP MRI applied science, at NVision Imaging Technologies, as well as Adjunct Full Professor at the University of California San Francisco, and Honorary Full Professor at Ulm University.
She received her PhD in Physics from the University of Paris-Sud. Her expertise is on developing and validating Hyperpolarized 13C-MR based methods for in vivo measurement of brain metabolism, in physiological and pathological conditions, in preclinical models and in patients.
Graduated in physics from the University of Glasgow and received his PhD in MR physics from the University of Sheffield. Currently Lecturer in Magnetic Resonance Physics at the University of Sheffield. Leads a lab within the POLARIS (Pulmonary, Lung and Respiratory Imaging Sheffield) group dedicated to the hyperpolarisation of xenon gas for ongoing research and clinical applications with 129Xe MRI.
His research interests span fundamental developments in nuclear spin polarisation physics to exploring new biomedical applications of hyperpolarised 129Xe NMR.
Graduated from Aarhus University in Molecular biology and received her PhD degree in medical research from the same university. She is currently an assistant professor at the MR Research centre, Aarhus University.
Her main focus and interests are the development of methods for the study of metabolism in cells and tissue specimens using hyperpolarized MR and biochemical methods.
Received his PhD in the development of methods for MR spectroscopy from ETH, Zürich. He is currently employed with GE as one of the lead developers of multinuclear MR methods.
His work focuses on the development of sequences and reconstruction methods for multi nuclear MR and, in particular, for hyperpolarized MR.
He is the developer of the Fidall package for doing multi-nuclear spectroscopy and imaging and reconstruction on GE systems.
Graduated in physics from Aarhus University and received his PhD in medical research from the same university. He is currently employed as an associate professor at the MR Research Centre, Aarhus University.
His main interests focus on the development of magnetic resonance methods and analysis tools.
Graduated from Aarhus University in biomedical engineering and received his PhD degree in medical research from the same university. He is currently employed as an onsite scientist from GE Healthcare working on collaborative projects with the MR Research Centre, Aarhus University.
His focus and interests are to develop the next generation clinical imaging methods. Specifically, in the implementation of hyperpolarized imaging and post-processing methods.